Avian Influenza A (H5N1) Immunization Program
A health care provider Q&A has been developed to support the introduction of the avian influenza vaccine program using Arepanrix™ H5N1. (July 2025)
Pneumococcal Conjugate Vaccine 20-Valent (PCV20) Immunization Program
A health care provider Q&A has been developed to support the introduction of the 20-valent pneumococcal conjugate vaccine, Prevnar 20™. (July 2025)
RNs/RPNs & Autonomous Ordering of Screening and Diagnostic Tests for the Purpose of CD Prevention and Management
A Q&A has been developed to support implementation of RNs/RPNs autonomous ordering of select laboratory screening and diagnostic tests with the issuance of a Medical Services Plan (MSP) practitioner number for the purpose of communicable disease prevention and managment. (November 2024)
BC Infant Respiratory Syncytial Virus (RSV) Immunoprophylaxis Program
A health care provider Q&A has been developed in collaboration with the BC Infant RSV Immunoprophylaxis Program to support the BeyfortusTM (nirsevimab) program in remote BC communities.
Pneumococcal conjugate 15-Valent and 20-Valent vaccines (PCV15 and PCV20) for adults
A health care provider Q&A has been developed to support immunization providers receiving questions regarding the 15-valent and 20-valent pneumococcal conjugate vaccines (PCV15 and PCV20) that have been authorized for adults. These vaccines are not currently publicly funded in B.C.
Informed Consent and Disagreeing Parents/Guardians
This Q&A document was developed to support immunization providers when there is disagreement between Parents/Guardians who both have the authority to consent to their child's immunization.
COVID-19 immunization program
A
health care provider Q&A page has been created specifically for the COVID-19 immunization program. The Q&A document includes general information about COVID-19 vaccines and questions and answers specific to the vaccines currently in use in BC.
Tdap vaccination during pregnancy
Beginning November 2020, Tdap (tetanus, diphtheria and pertussis) vaccine will be provided free to people who are pregnant in every pregnancy. Vaccination is recommended at 27-32 weeks of gestation but it may be given from 13 weeks up to the time of delivery. The aim of this new program is to protect newborn infants in BC from severe outcomes related to pertussis infection. It is anticipated that Tdap vaccine will be provided mainly by prenatal care providers including family doctors and midwives, but can also be provided by specialty prenatal care service providers and by community-based pharmacists, or at the local health unit at adult immunization clinics.
Vaccine Status Reporting Regulation (VSRR)
Vaccine Status Reporting Regulation Information for Health Care Providers - Q&A (PDF, January 2020)
Seasonal influenza
